NCT00151918View on ClinicalTrials.gov

Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 7, 2005

Primary Completion Date

August 22, 2005

Study Completion Date

August 22, 2005

Conditions
Kidney Failure, Chronic
Interventions
DRUG

Lanthanum carbonate

Sponsors

Lead Sponsor

Shire
All Listed Sponsors
lead

Shire

INDUSTRY